Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| NYSE | USD | Real-time | ||
| Mexico | MXN | Delayed | ||
| Stockholm | SEK | Real-time | ||
| Frankfurt | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Hamburg | EUR | Delayed | ||
| Xetra | EUR | Delayed | ||
| Santiago | USD | Delayed | ||
| Buenos Aires | ARS | Delayed | ||
| BM&FBovespa | BRL | Delayed | ||
| Vienna | EUR | Delayed | ||
| KASE | USD | Delayed | ||
| Colombia | COP | Delayed | ||
| Lima | USD | Delayed |
(Reuters) -Pfizer Inc Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19. "I’m feeling well and symptom free," Bourla said in a statement....
(Reuters) – Pfizer Inc Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19.
By Natalie Grover LONDON (Reuters) -Haleon believes it is not liable for any claims that may arise from U.S. litigation over the heartburn drug Zantac, the London-listed company's...
Fauci, Klain, Yellen, Kendi Headline Pfizer-Funded, Far-Left Conference In D.C. This Week Authored by Raheem J. Kassam and Natalie Winters via The National Pulse, Anthony Fauci is...
Omicron BA.1 bivalent vaccinesCHMP separately recommends approval of booster dose of COMIRNATY® in children 5 through 11 years of age in the European Union NEW YORK and MAINZ,...
A federal suit says a fellowship program bars Asians and whites.
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The Company's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.
| Average | 58.736 (+33.25% Upside) |
| High | 75 |
| Low | 46 |
| Price | 44.08 |
| No. of Analysts | 22 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
| Technical Indicators | Strong Sell | Strong Sell | Neutral | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Sell | Strong Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 590.00 | 590.00 | 590.00 | -15.00 | -2.52% | 10.43K | London | |||
| 1,090.00 | 1,090.00 | 1,090.00 | 0.00 | 0.00% | 6.85K | London | |||
| 306.60 | 328.20 | 304.60 | -15.80 | -4.90% | 5.78M | London | |||
| 956.00 | 956.00 | 938.00 | +18.00 | +1.92% | 80.98K | London | |||
| 11,320.00 | 114.80 | 112.00 | +11,207.00 | +1,000.00% | 460.92K | London | |||
| 535.80 | 570.20 | 530.20 | -33.80 | -5.93% | 2.91M | London | |||
| 108.12 | 109.92 | 107.48 | -0.74 | -0.68% | 74.39M | London | |||
| 196.45 | 208.30 | 195.15 | -8.15 | -3.98% | 4.00M | London | |||
| 118.90 | 120.20 | 115.00 | -0.10 | -0.08% | 1.20M | London | |||
| 845.50 | 895.00 | 843.50 | -48.00 | -5.37% | 484.45K | London | |||
| 3,386.50 | 3,497.50 | 3,382.00 | -77.0 | -2.22% | 2.54M | London | |||
| 137.45 | 142.35 | 136.70 | -4.90 | -3.44% | 6.06M | London | |||
| 24.25 | 24.25 | 24.25 | -0.75 | -3.00% | 265.42K | London | |||
| 71.88 | 75.26 | 70.47 | -1.39 | -1.90% | 55.14M | London | |||
| 57.25 | 59.00 | 56.90 | -1.55 | -2.64% | 11.04M | London |